{{Rsnum
|rsid=17157903
|Gene=RELN
|Chromosome=7
|position=103987589
|Orientation=plus
|GMAF=0.1612
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=RELN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 77.0 | 21.2 | 1.8
| HCB | 45.3 | 48.2 | 6.6
| JPT | 56.6 | 35.4 | 8.0
| YRI | 79.5 | 18.5 | 2.1
| ASW | 83.9 | 16.1 | 0.0
| CHB | 45.3 | 48.2 | 6.6
| CHD | 59.6 | 33.0 | 7.3
| GIH | 64.0 | 35.0 | 1.0
| LWK | 86.4 | 13.6 | 0.0
| MEX | 82.5 | 17.5 | 0.0
| MKK | 77.4 | 21.3 | 1.3
| TSI | 72.5 | 24.5 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000003
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs17157903
|Name_s=
|Gene_s=RELN
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 7q22.1; Reported Gene(s): RELN; Risk Allele: rs17157903-?); (p-value= 0.000003).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740723
}}

{{PMID Auto
|PMID=19639606
|Title=Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17157903
|overall_frequency_n=16
|overall_frequency_d=128
|overall_frequency=0.125
|n_genomes=13
|n_genomes_annotated=0
|n_haplomes=13
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=23563089
|Title=Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}